-
-
-
-
-
-
-
Artivion Inc. (AORT) PT Lowered to $36 at Canaccord
-
-
-
-
-
-
-
Artivion gets FDA approval for NEXUS aortic arch system, considers acquisition
-
-
-
-
-
-
-
Artivion Inc. (AORT) PT Raised to $50 at Oppenheimer
-
-
-
-
-
-
-
Artivion Inc. (AORT) PT Raised to $46 at Stifel
-
-
-
-
-
-
-
Artivion Inc. (AORT) PT Raised to $40 at Oppenheimer
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Artivion Inc. (AORT)
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Artivion Inc. (AORT)
-
435,069 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

